8-CHLORO-2,3-DIHYDRO-1H-PYRIDO[2,3-B][1,4]OXAZINE
- $220 - $752
- Product name: 8-CHLORO-2,3-DIHYDRO-1H-PYRIDO[2,3-B][1,4]OXAZINE
- CAS: 1198154-60-7
- MF: C7H7ClN2O
- MW: 170.59628
- EINECS:
- MDL Number:MFCD20688279
- Synonyms:8-CHLORO-2,3-DIHYDRO-1H-PYRIDO[2,3-B][1,4]OXAZINE;8-Chloro-1h,2h,3h-pyrido[2,3-b][1,4]oxazine;1H-Pyrido[2,3-b][1,4]oxazine, 8-chloro-2,3-dihydro-
4 prices
Selected condition:
Brand
- Alichem
- Chemcia Scientific
- Crysdot
- TRC
Package
- 50mg
- 0.5g
- 1g
- ManufacturerAlichem
- Product number1198154607
- Product description8-Chloro-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine
- Packaging1g
- Price$718.2
- Updated2021-12-16
- Buy
- ManufacturerChemcia Scientific
- Product numberAA10-1401
- Product description8-Chloro-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine 95%
- Packaging0.5g
- Price$535
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11333927
- Product description8-Chloro-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine 95+%
- Packaging1g
- Price$752
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberC382970
- Product description8-Chloro-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine
- Packaging50mg
- Price$220
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Alichem | 1198154607 | 8-Chloro-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine | 1g | $718.2 | 2021-12-16 | Buy |
Chemcia Scientific | AA10-1401 | 8-Chloro-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine 95% | 0.5g | $535 | 2021-12-16 | Buy |
Crysdot | CD11333927 | 8-Chloro-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine 95+% | 1g | $752 | 2021-12-16 | Buy |
TRC | C382970 | 8-Chloro-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine | 50mg | $220 | 2021-12-16 | Buy |
Properties
Boiling point :301.2±42.0 °C(Predicted)
Density :1.327±0.06 g/cm3(Predicted)
pka :4.57±0.20(Predicted)
Density :1.327±0.06 g/cm3(Predicted)
pka :4.57±0.20(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|